Brandon S. Sheffield, Julie Lorette, Yaoqing Shen, Marco A. Marra, and Andrew Churg (2016) Immunohistochemistry for NF2, LATS1/2, and YAP/TAZ Fails to Separate Benign From Malignant Mesothelial Proliferations. Archives of Pathology & Laboratory Medicine: May 2016, Vol. 140, No. 5, pp. 391-391.

LETTERS TO THE EDITOR

Immunohistochemistry for NF2, LATS1/2, and YAP/TAZ Fails to Separate Benign From Malignant Mesothelial Proliferations

Brandon S. Sheffield , MD¹; Julie Lorette , MLT²; Yaoqing Shen , MD³; Marco A. Marra , PhD^3,4; Andrew Churg , MD^1,5

¹ Departments of Pathology and Laboratory Medicine and

⁴ Medical Genetics, University of British Columbia, Vancouver, Canada;

² Department of Pathology and

³ Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada;

⁵ Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada